Injectable cabotegravir is being tested by the NIH in an effort to develop other HIV prevention options. Currently, the oral tablet Truvada is the only HIV pre-exposure prophylaxis approved for use.
Public Health December 29, 2016
A clinical trial in Australia for the new HIV drug recruits over 1,100 participants. According to doctors, the PrEP drug called Truvada could help in significantly reducing the rates of infection.
Medicine May 24, 2016